These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 21296901)

  • 1. Endocrine and immune substrates of depressive symptoms and fatigue in multiple sclerosis patients with comorbid major depression.
    Gold SM; Krüger S; Ziegler KJ; Krieger T; Schulz KH; Otte C; Heesen C
    J Neurol Neurosurg Psychiatry; 2011 Jul; 82(7):814-8. PubMed ID: 21296901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circadian cortisol and fatigue severity in relapsing-remitting multiple sclerosis.
    Powell DJ; Moss-Morris R; Liossi C; Schlotz W
    Psychoneuroendocrinology; 2015 Jun; 56():120-31. PubMed ID: 25817406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperstable arousal regulation in multiple sclerosis.
    Stoppe M; Meyer K; Schlingmann M; Olbrich S; Then Bergh F
    Psychoneuroendocrinology; 2019 Dec; 110():104417. PubMed ID: 31546115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour?
    Heesen C; Nawrath L; Reich C; Bauer N; Schulz KH; Gold SM
    J Neurol Neurosurg Psychiatry; 2006 Jan; 77(1):34-9. PubMed ID: 16361589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time matters - acute stress response and glucocorticoid sensitivity in early multiple sclerosis.
    Kern S; Rohleder N; Eisenhofer G; Lange J; Ziemssen T
    Brain Behav Immun; 2014 Oct; 41():82-9. PubMed ID: 24880115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study.
    Vreeburg SA; Hoogendijk WJ; van Pelt J; Derijk RH; Verhagen JC; van Dyck R; Smit JH; Zitman FG; Penninx BW
    Arch Gen Psychiatry; 2009 Jun; 66(6):617-26. PubMed ID: 19487626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circadian cortisol, depressive symptoms and neurological impairment in early multiple sclerosis.
    Kern S; Schultheiss T; Schneider H; Schrempf W; Reichmann H; Ziemssen T
    Psychoneuroendocrinology; 2011 Nov; 36(10):1505-12. PubMed ID: 21621332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive impairment correlates with hypothalamo-pituitary-adrenal axis dysregulation in multiple sclerosis.
    Heesen C; Gold SM; Raji A; Wiedemann K; Schulz KH
    Psychoneuroendocrinology; 2002 May; 27(4):505-17. PubMed ID: 11912002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypothalamic-pituitary-adrenal axis function and cytokine production in multiple sclerosis with or without interferon-beta treatment.
    Limone P; Ferrero B; Calvelli P; Del Rizzo P; Rota E; Berardi C; Barberis AM; Isaia GC; Durelli L
    Acta Neurol Scand; 2002 May; 105(5):372-7. PubMed ID: 11982488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypothalamic-pituitary-adrenal axis activity in the comorbidity between obsessive-compulsive disorder and major depression.
    Labad J; Soria V; Salvat-Pujol N; Segalàs C; Real E; Urretavizcaya M; de Arriba-Arnau A; Ferrer A; Crespo JM; Jiménez-Murcia S; Soriano-Mas C; Alonso P; Menchón JM
    Psychoneuroendocrinology; 2018 Jul; 93():20-28. PubMed ID: 29684711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypothalamic-pituitary-adrenal axis activity and cognition in major depression: The role of remission status.
    Salvat-Pujol N; Labad J; Urretavizcaya M; de Arriba-Arnau A; Segalàs C; Real E; Ferrer A; Crespo JM; Jiménez-Murcia S; Soriano-Mas C; Menchón JM; Soria V
    Psychoneuroendocrinology; 2017 Feb; 76():38-48. PubMed ID: 27883963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined treatment with corticosteroids and moclobemide favors normalization of hypothalamo-pituitary-adrenal axis dysregulation in relapsing-remitting multiple sclerosis: a randomized, double blind trial.
    Then Bergh F; Kümpfel T; Grasser A; Rupprecht R; Holsboer F; Trenkwalder C
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1610-5. PubMed ID: 11297592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlates of cognitive dysfunction in multiple sclerosis.
    Heesen C; Schulz KH; Fiehler J; Von der Mark U; Otte C; Jung R; Poettgen J; Krieger T; Gold SM
    Brain Behav Immun; 2010 Oct; 24(7):1148-55. PubMed ID: 20621641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cortisol and development of depression in adolescence and young adulthood - a systematic review and meta-analysis.
    Zajkowska Z; Gullett N; Walsh A; Zonca V; Pedersen GA; Souza L; Kieling C; Fisher HL; Kohrt BA; Mondelli V
    Psychoneuroendocrinology; 2022 Feb; 136():105625. PubMed ID: 34920399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of the hypothalamic-pituitary-adrenal axis and inflammatory mediators in major depressive disorder with or without metabolic syndrome.
    Martinac M; Babić D; Bevanda M; Vasilj I; Glibo DB; Karlović D; Jakovljević M
    Psychiatr Danub; 2017 Mar; 29(1):39-50. PubMed ID: 28291973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscle Fatigability During a Sustained Index Finger Abduction and Depression Scores Are Associated With Perceived Fatigue in Patients With Relapsing-Remitting Multiple Sclerosis.
    Wolkorte R; Heersema DJ; Zijdewind I
    Neurorehabil Neural Repair; 2015 Sep; 29(8):796-802. PubMed ID: 25605633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatigue in female patients with major depression: the effect of comorbid anxiety disorders.
    Ferentinos P; Kontaxakis VP; Havaki-Kontaxaki BJ; Dikeos D; Papadimitriou GN; Lykouras L
    Psychiatriki; 2011; 22(4):320-9. PubMed ID: 22271845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased cortisol awakening response was associated with time to recurrence of major depressive disorder.
    Hardeveld F; Spijker J; Vreeburg SA; Graaf RD; Hendriks SM; Licht CM; Nolen WA; Penninx BW; Beekman AT
    Psychoneuroendocrinology; 2014 Dec; 50():62-71. PubMed ID: 25179322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RELATIONSHIP BETWEEN THE CORTICAL THICKNESS AND SERUM CORTISOL LEVELS IN DRUG-NAÏVE, FIRST-EPISODE PATIENTS WITH MAJOR DEPRESSIVE DISORDER: A SURFACE-BASED MORPHOMETRIC STUDY.
    Liu X; Kakeda S; Watanabe K; Yoshimura R; Abe O; Ide S; Hayashi K; Katsuki A; Umeno-Nakano W; Watanabe R; Ueda I; Moriya J; Nakamura J; Korogi Y
    Depress Anxiety; 2015 Sep; 32(9):702-8. PubMed ID: 26290363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypothalamo-pituitary-adrenal function in patients with depressive disorders is correlated with baseline cytokine levels, but not with cytokine responses to hydrocortisone.
    Schuld A; Schmid DA; Haack M; Holsboer F; Friess E; Pollmächer T
    J Psychiatr Res; 2003; 37(6):463-70. PubMed ID: 14563377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.